David L. Hudson, Jr. is a First Amendment Scholar with the First Amendment Center at Vanderbilt University. He teaches at Vanderbilt University Law School and Nashville School of Law. He is the author of Let the Students Speak!: A History...
18 posts from March 2012
The poet Adrienne Rich passed away yesterday.
Want to read something longer than a tweet but shorter than book? Here are today's recommendations from Beacon Press.
Life is being restored to significant portions of the Lower Ninth Ward of New Orleans, and the heroes of this effort are fiercely determined residents who have returned to their blocks and rebuilt their homes.
The intersection of mental health and "trendy" prescriptions, and what it means for patients.
Links and distractions from the (standing) desk of our blog editor.
Author Sam Skolnik discusses the hidden costs of gambling.
Edward Cullen as a ruthless CEO with bondage fetish? You have now entered the Twilight fanfic zone.
Youth sports is more than just a fun pastime. It's an incredibly profitable market, and it's become crowded with companies and individuals eager to reap the rewards.
William Ayers looks at how we can envision education as something other than just a commodity, and to teach for a democratic society.
The White Bread blog tour has been sliced and wrapped, but you can still get a taste in our roundup.
We've all heard the cliché, and we all know its meaning. But Jay Michaelson suggests a different reading of the creation story.
"Death" and "severe, life-changing injury" are just some of the possible side effects of stem-cell tourism in the Lone Star State.
Cheating Justice looks at how the ex-president and vice-president can be held personally accountable, and how they tried to manipulate the system from inside to keep themselves from being held to account.
Jumped In is a chronicle of the unexpected lessons gang members taught a professor as she was busily studying them, and how they changed her forever.
What do we think about when we think about "White Bread"?
A new blog tour launches, and a bunch of other great mentions for Beacon books.
Glaxo Smith-Kline heroically funds a new research prize in the face of the naysayers who get upset about a little fraud.